Intended for healthcare professionals


Explaining about possible adverse events may reduce problems

BMJ 1996; 313 doi: (Published 14 December 1996) Cite this as: BMJ 1996;313:1553
  1. Ron Behrens
  1. Consultant in tropical and travel medicine Travel Clinic, 4 St Pancras Way, London NW1 0PE

    EDITOR,—The adverse events reported by P J Barrett and colleagues in travellers taking mefloquine, who were recruited to the study when seeking telephone advice,1 were subjectively much more severe and disabling than those described in a study from Swiss, Swedish, and American researchers published around the same time2.

    Schlagenhauf …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription